Advance articles

Isavuconazole therapeutic drug monitoring and association with adverse events

Abstract
• View article

Antibiotic treatment of Stenotrophomonas maltophilia bacteraemia: does trimethoprim/sulfamethoxazole dose affect clinical outcomes?

Abstract
• View article
• Supplementary data

Impact of the inoculum effect on cefepime activity against AmpC-hyperproducing Enterobacter spp.: insights into resistance mechanisms

Abstract
• View article
• Supplementary data

Effect of body mass index on the timing of therapeutic drug monitoring—guided dalbavancin dosing in patients with osteoarticular infections

Abstract
• View article

Ultrasound for long-acting injectable cabotegravir and rilpivirine in transgender individuals with implants: a new opportunity for normalization

Extract
• View article

Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review

Abstract
• View article

Changing epidemiology of MRSA-CC398 in Spanish hospitals located in areas with different pig farming densities: a 2023 multicentre study

Abstract
• View article
• Supplementary data

Interventions to improve antibiotic use among dentists: a systematic review and meta-analysis

Abstract
• View article
• Supplementary data

Single-cell analysis of antimicrobial compound–induced cell death of bacterial cells

Abstract
• View article

Detection of a novel SME-6 Carbapenemase in Serratia ureilytica in Germany

Abstract
• View article
• Supplementary data

Optimising antiretroviral therapy through a proactive treatment algorithm: a cost-effective strategy in Dutch healthcare for people with HIV

Abstract
• View article

Ceftazidime/avibactam for the treatment of bloodstream infection due to carbapenemase-producing Enterobacterales in onco-haematologic neutropenic patients (the TARZAN study)

Abstract
• View article
• Supplementary data

Tetracyclines at subinhibitory concentrations are lethal for NADH peroxidase–deficient mutants of Enterococcus faecium

Abstract
• View article
• Supplementary data

Clinical features and medical–surgical management overweight the inoculum effect and genotypic characteristics of MSSA in infective endocarditis

Abstract
• View article
• Supplementary data

The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment

Abstract
• View article

The 2023 Garrod Lecture: Antimicrobial use and stewardship in primary care: what works, and what next?

Extract
• View article

Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model

Abstract
• View article
• Supplementary data

Helicobacter pylori culture positivity and antimicrobial susceptibility profiles (Vancouver, Canada)

Abstract
• View article

Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study)

Abstract
• View article
• Supplementary data

Impact of fluoroquinolone exposure on the diagnosis and prognosis of tuberculosis in immunocompromised patients: a propensity-score-matched, competing risk analysis

Abstract
• View article
• Supplementary data

Evaluation of an optimized intermittent vancomycin dosing regimen in infants

Abstract
• View article

Unravelling the genetic contributors to linezolid resistance in Mycobacterium smegmatis: insights from a transposon library

Abstract
• View article
• Supplementary data

Population pharmacokinetics and optimized prophylaxis dosing of cefazolin during transcatheter aortic valve implantation

Abstract
• View article
• Supplementary data

Holistic analysis of the determinants of antibiotic prescription in primary care in France: a cross-sectional study with nationwide panel data

Abstract
• View article

In vitro, intracellular and in vivo synergy between amoxicillin, imipenem and relebactam against Mycobacterium abscessus

Abstract
• View article
• Supplementary data

Dual versus sequenial therapy using rifaximin and MTZ in a patient with intestinal methanogen overgrowth—a case report

Extract
• View article

Pandemic human-associated extended-spectrum β-lactamase-producing Escherichia coli lineages of ST38, ST131 and ST141 identified in Viennese dogs

Abstract
• View article
• Supplementary data

Cross-resistance to 14-, 15- and 16-membered ring macrolides in Salmonella and Campylobacter

Abstract
• View article
• Supplementary data

Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens

Abstract
• View article
• Supplementary data

Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials

Abstract
• View article
• Supplementary data

Adequate posology of antimicrobial therapy in the septic critically ill in continuous veno-venous hemofiltration: a single centre prospective observational study

Abstract
• View article
• Supplementary data

Population pharmacokinetics and exposure–response relationship of the antituberculosis drug BTZ-043

Abstract
• View article
• Supplementary data

Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients

Abstract
• View article
• Supplementary data

Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model

Abstract
• View article
• Supplementary data

Population pharmacokinetic model of oral minocycline in critically ill adult patients with ventilator-associated pneumonia

Abstract
• View article
• Supplementary data

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–21

Abstract
• View article
• Supplementary data

Bactericidal activity of antibiotic combinations against clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus

Abstract
• View article
• Supplementary data

Biannual azithromycin mass drug administration for reduction of childhood mortality: a systematic review and meta-analysis

Abstract
• View article
• Supplementary data

A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?

Abstract
• View article
• Supplementary data

Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America

Abstract
• View article
• Supplementary data

Nature-inspired designing of KLR- and KLS-rich antimicrobial peptides: unleashing the antibiofilm potential of RbP12 against MDR S. aureus and P. aeruginosa

Abstract
• View article
• Supplementary data

A retrospective observational cohort study of oral azithromycin treatment for Legionnaires’ disease

Abstract
• View article
• Supplementary data

Utilizing dried blood spot micro-sampling and population pharmacokinetic modelling and simulation to inform ampicillin dosing in Chinese neonates

Abstract
• View article
• Supplementary data

The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis

Extract
• View article
• Supplementary data

Correction to: Linezolid brain penetration in neurointensive care patients

Extract
• View article

Screening for carbapenemase-producing Enterobacterales (CPE)—considering the practical implications of molecular results, the value of culture and deciding criteria for resistance

Abstract
• View article
• Supplementary data

Prophylaxis against Pneumocystis jirovecii pneumonia and toxoplasmosis with low-dose Trimethoprim-sulfamethoxazole (cotrimoxazole 20/100 mg) in heart transplant patients. The PAPTO-LOCO observational comparative study

Abstract
• View article
• Supplementary data

Ceftazidime-avibactam plus aztreonam cocktail for the treatment of VIM-producing Pseudomonas aeruginosa infections: good enough to have another?

Abstract
• View article

First report of SME-carbapenemase–producing Serratia marcescens in France

Extract
• View article

In vitro susceptibility testing of vancomycin-resistant Enterococcus faecium to fosfomycin

Extract
• View article